Notice: This company recently went public with an IPO on Friday, September 13th 2024. They issued 10,200,000 shares at $16.00 per share. We will continue to update data for MBX as it becomes available.

MBX Biosciences (MBX) Competitors

$21.23

+0.23 (+1.10%)

(As of 09/19/2024 ET)

Compare

MBX vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCAX, BCTXW, CDIOW, CTCXW, and CELUW

Should you be buying MBX Biosciences stock or one of its competitors? The main competitors of MBX Biosciences include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), Bicara Therapeutics (BCAX), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.

MBX Biosciences vs.

MBX Biosciences (NYSE:MBX) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, community ranking, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MBX Biosciences
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
180 Life Sciences
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: In the previous week, MBX Biosciences had 4 more articles in the media than 180 Life Sciences. MarketBeat recorded 4 mentions for MBX Biosciences and 0 mentions for 180 Life Sciences. MBX Biosciences' average media sentiment score of 1.23 beat 180 Life Sciences' score of 1.00 indicating that MBX Biosciences is being referred to more favorably in the media.
Company Overall Sentiment
MBX Biosciences Positive
180 Life Sciences Positive
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
MBX Biosciences N/A N/A N/A N/A N/A
180 Life Sciences N/A N/A N/A N/A N/A
: Company Net Margins Return on Equity Return on Assets
MBX Biosciences N/A N/A N/A
180 Life Sciences N/A N/A N/A
: MBX Biosciences and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
Company Underperform Outperform
MBX Biosciences N/A N/A
180 Life Sciences N/A N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MBX Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
180 Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Overall Sentiment
MBX Biosciences	Positive
180 Life Sciences	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MBX Biosciences	N/A	N/A	N/A	N/A	N/A
180 Life Sciences	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
MBX Biosciences	N/A	N/A	N/A
180 Life Sciences	N/A	N/A	N/A

Company	Underperform	Outperform
MBX Biosciences	N/A	N/A
180 Life Sciences	N/A	N/A

Summary

MBX Biosciences beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks.

Ad InvestorPlace

“I’ll Give You the Knowledge and Confidence You Need to Make Your First Options Trade in Five Days or Less… Guaranteed!”

Starting Monday, September 23 — a veteran 25-year Chicago Options Exchange market-maker will show you his UOA options secret that could help you consistently target gains of 126%… 245%… even 463% or more… Often in 30 days or less… No matter what the market is doing right now.

Go here for the full details now.

Get MBX Biosciences News Delivered to You Automatically

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MBX vs. The Competition

Export to Excel

Metric	MBX Biosciences	Biotechnology Industry	Medical Sector	NYSE Exchange
Market Cap	N/A	$267.42M	$5.69B	$19.22B
Dividend Yield	N/A	3.44%	4.97%	3.53%
P/E Ratio	N/A	323.69	146.07	26.49
Price / Sales	N/A	11,680.86	1,658.38	14.78
Price / Cash	N/A	12.23	37.23	19.91
Price / Book	N/A	7.05	4.92	5.15
Net Income	N/A	-$32.19M	$115.07M	$982.70M
7 Day Performance	N/A	0.13%	6.32%	5.77%
1 Month Performance	N/A	5.53%	7.10%	4.68%
1 Year Performance	N/A	12.13%	31.55%	22.11%

MBX Biosciences Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	Employee Count	Indicator(s)
ATNFW 180 Life Sciences	0 of 5 stars 0.00 / 5 stars	$0.01 flat	N/A	-38.3%	$0.00	N/A	7	Positive News Gap Up
SXTPW 60 Degrees Pharmaceuticals	0 of 5 stars 0.00 / 5 stars	$0.04 flat	N/A	N/A	$0.00	$418,304.00	2	Positive News
DRTSW Alpha Tau Medical	0 of 5 stars 0.00 / 5 stars	$0.18 -10.0%	N/A	-35.1%	$0.00	N/A	80	Positive News
WENAW Anew Medical	0 of 5 stars 0.00 / 5 stars	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	Gap Down
APLMW Apollomics	0 of 5 stars 0.00 / 5 stars	$0.01 flat	N/A	-86.6%	$0.00	N/A	59
BCAX Bicara Therapeutics	0 of 5 stars 0.00 / 5 stars	$27.07 +6.5%	N/A	N/A	$0.00	N/A	32	Insider Buying News Coverage
BCTXW BriaCell Therapeutics	0 of 5 stars 0.00 / 5 stars	$0.19 +19.3%	N/A	-90.4%	$0.00	N/A	8	Gap Down
CDIOW Cardio Diagnostics	0 of 5 stars 0.00 / 5 stars	$0.03 flat	N/A	N/A	$0.00	$39,138.00	7	Positive News
CTCXW Carmell	0 of 5 stars 0.00 / 5 stars	$0.06 flat	N/A	-72.7%	$0.00	$12,320.00	9	Positive News
CELUW Celularity	0 of 5 stars 0.00 / 5 stars	$0.02 flat	N/A	-47.6%	$0.00	$22.77M	220